Merck
MRK
#55
Rank
$274.84 B
Marketcap
$111.28
Share price
-0.09%
Change (1 day)
39.75%
Change (1 year)

P/S ratio for Merck (MRK)

P/S ratio as of May 2026 (TTM): 4.18

According to Merck's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.22. At the end of 2026 the company had a P/S ratio of 4.50.

P/S ratio history for Merck from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20264.509.96%
20254.094.06%
20243.93-14.47%
20234.60-3.15%
20224.7519.38%
20213.97-13.85%
20204.61-6.41%
20194.935.25%
20184.6822.58%
20173.82-6.29%
20164.089.63%
20153.72-2.54%
20143.8214.68%
20133.3326.93%
20122.629.62%
20112.39-0.99%
20102.42-41.67%
20094.1453.66%
20082.69-48.35%
20075.2224.95%
20064.1832.42%
20053.151.89%
20043.09-32.21%
20034.5658.76%
20022.881.15%
20012.84

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Johnson & Johnson
JNJ
5.53 32.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4.90 17.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.32-44.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.19-23.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
11.9 185.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
4.78 14.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.84-56.07%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
2.34-43.89%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2.26-45.82%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
2.41-42.43%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel